Trial intelligence / Profile preview

Paromomycin sulfate as a non-absorbable marker to evaluate gastrointestinal transit

2013-000297-30Phase 4Completed

Sponsor
KU Leuven
Start
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of paromomycin, sponsored by KU Leuven. Started Feb 2013; status: completed.

02

Drugs

paromomycin

Beyond the preview

Go deeper on 2013-000297-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-000297-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call